Palliation of Oral Mucositis Symptoms in Pediatric Patients Treated with Cancer Chemotherapy

Cancer Nursing

Volumn 26, Issue 6, 2003, Pages 476-484

  Cheng, K K F ^a,c   Chang, A M ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Chemotherapy; Children; Mouthwashes; Oral care; Oral mucositis; Symptoms

Indexed keywords

ALKALOID DERIVATIVE; ANTIMETABOLITE; ANTINEOPLASTIC ANTIBIOTIC; BENZYDAMINE; CHLORHEXIDINE;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BONE CANCER; CANCER CHEMOTHERAPY; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; EATING; EVALUATION; FEMALE; HUMAN; LEUKEMIA; LIVER CANCER; LYMPHOMA; MALE; MOUTHWASH; MUCOSA INFLAMMATION; PAIN; PALLIATIVE THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SOFT TISSUE SARCOMA; SYMPTOM; VISUAL ANALOG SCALE;

EID: 0347627165     PISSN: 0162220X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002820-200312000-00007     Document Type: Article

References (42)

1. Madeya ML. Oral complications from cancer therapy: 1, pathophysiology and secondary complications. Oncol Nurs Forum. 1996;23(5):801-817.
2. Bonnaure-Mallet M, Bunetel L, Tricot-Doleux S, et al. Oral complications during treatment of malignant diseases in childhood: effects of tooth brushing. Eur J Cancer. 1998;34(10):1588-1591.
3. Childers NK, Stinnett EA, Wheeler P, et al. Oral complications in children with cancer. Oral Surg Oral Med Oral Path. 1993;75:41-47.
4. Bellm LA, Epstein JB, Rose-Ped P, et al. Patient reports of complications of bone marrow transplantation. Support Care Cancer. 2000;8:33-39.
5. Wilkes JD. Prevention and treatment of oral mucositis following cancer chemotherapy. Semin Oncol. 1998;25(5):538-551.
6. Woo SW, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of ulcerative mucositis in bone marrow transplant recipients. Cancer. 1993; 72:1612-1617.
7. Zerbe MB, Parkerson SG, Ortlieb ML, Spitzer T. Relationships between oral mucositis and treatment variables in bone marrow transplant patients. Cancer Nurs. 1992;15(3):196-205.
8. Miser AW, Dithage JA, Wesley RA, Miser JS. The prevalence of pain in a pediatric and young adult cancer population. J Pain Symptom Manage. 1987;29:73-83.
9. Walco GA, Sterling CM, Conte PM, et al. Empirically supported treatments in pediatric psychology: disease-related pain. J Soc Ped Psychol. 1999; 375-392.
10. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol. 2001;19(8):2201-2205.
11. Bolwell BJ, Kalaycio M, Sobecks R, et al. A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation. Bone Marrow Transplant. 2002;30:587-591.
12. Borbasi S, Cameron K, Quested B, et al. More than a sore mouth: patients' experience of oral mucositis. Oncol Nur Forum. 2002;29(7): 1051-1057.
13. Meropol NJ, Clamon GH, Pelley RJ, et al. Measuring the impact of mucositis on quality of life. Proc Annu Meet Am Soc Clin Oncol. 1997; 16(A266).
14. Dodd MJ, Dibble S, Miaskowski C, et al. A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. J Pain Symptom Manage. 2001;21(6):498-505.
15. Calman FMB, Langdon J. Oral complications of cancer. Br Med J. 1991; 302:485-486.
16. Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 1998;34: 39-43.
17. Berger AM, Eilers J. Factors influencing oral cavity status during high-dose antineoplastic therapy: a secondary data analysis. Oral Oncol Forum. 1998;25(9):1623-1626.
18. Dodd MJ, Miaskowski C, Shiba GH, et al. Risk factors for chemotherapy-induced oral mucositis: dental appliances, oral hygiene, previous oral lesions, and history smoking. Cancer Invest. 1999;17(4):278-284.
19. Weitman S, Kamen BA. Cancer chemotherapy and pharmacology in children. In: Schilsky RL, Milano GA, Ratain MJ, eds. Principles of Antineoplastic Drug Development and Pharmacology. New York: Marcel Dekker; 1996:375-392.
20. Clarkson JE, Worthington HC, Eden OB. Interventions for preventing oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy. Cochrane Database Systematic Rev. 2002;3.
21. Kowanko I, Long L, Hodgkinson B, Evans D. The Effectiveness of Strategies for Preventing and Treating Chemotherapy and Radiation Induced Oral Mucositis in Patients With Cancer: A Systematic Review. Adelaide: The Joanna Briggs Institute for Evidence Based Nursing and Midwifery; 1998.
22. Mueller BA, Millheim ET, Farrington EA, et al. Mucositis management practices for hospitalised patients: national survey results. J Pain Symptom Manage. 1995;10(7):510-520.
23. Cheng KKF, Molassiotis A, Chang AM, et al. Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Cancer. 2001;37:2056-2063.
24. Levy-Polack MP, Sebelli P, Polack NL. Incidence of oral complications and application of a preventive protocol in children with acute leukemia. Special Care Dent. 1998;18(5):189-193.
25. Rutkauskas JS, Davis JW. Effects of chlorhexidine during immunosuppressive chemotherapy: a preliminary report. Oral Surg Oral Med Oral Path. 1993;76(4):441-448.
26. Dodd MJ, Larson PJ, Dibble SL, et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncol Nurs Forum. 1996;23(6):921-927.
27. Kennedy L, Diamond J. Assessment and management of chemotherapy-induced mucositis in children. J Ped Oncol Nurs. 1997;14:164-174.
28. Kim JH, Lakshmi V. Benzydamine HCl, a new agent for the treatment of radiation mucositis of the oropharynx. Am J Clin Oncol. 1986;9(2): 132-134.
29. Epstein JB, Stevenson-Moore P, Jackson S, et al. Prevention of oral mucositis in radiation therapy: a controlled study with benzydamine hydrochloride rinse. Int J Radiat Oncol Bio Phy. 1989;16:1571-1575.
30. Epstein JB, Silverman S, Paggiarino DA, et al. Benzydamine HCL for prophylaxis of radiation-induced oral mucositis. Cancer. 2001;92:875-885.
31. Ernst CP, Prockl K, Willerhausen B. The effectiveness and side effects of 0.1% and 0.2% of chlorhexidine mouthrinses: a clinical study. Quintessence Int. 1998;29(7):443-448.
32. Pothmann R. Comparison of the visual analog scale and a smiley analog scale for the evaluation of pain in children. In: Tyler DC, Krane EJ, eds. Advances in Pain Research and Therapy. New York: Raven Press; 1990: 95-99.
33. McGrath PJ, Beyer J, Cleenland C, et al. Report of the subcommittee on assessment and methodologic issues in the management of pain in childhood cancer. Pediatrics. 1990;814-817.
34. Pocock SL. Clinical Trials: A Practical Approach. New York: Wiley; 1996.
35. Pederson C, Parran L. Pain and distress in adults and children undergoing peripheral blood stem cell or bone marrow transplant. Oncol Nurs Forum. 1999;26(3):575-582.
36. Rask C, Albertioni F, Bentzen SM, et al. Clinical and pharmacokinetic risk factors for high-dose methtrexate-induced toxicity in children with acute lymphoblastic leukemia: a logistic regression analysis. Acta Oncol. 1998;37:277-284.
37. Groenwald SL, Frogge MH, Goodman M, Yarbro CH. Cancer Nursing: Principles and Practice. 3rd ed. Massachusetts: Jones & Barlert; 1993.
38. Samaranayake LP, Robertson AG, MacFarlane TW, et al. The effect of chlorhexidine and benzydamine mouthwashes on mucositis induced by therapeutic irradiation. Clin Radiol. 1988;39:291-294.
39. Donaldson GW, Moinpour CM. Strengthened estimates of individual pain trends in children following bone marrow transplantation. Pain. 1992;48:147-155.
40. Schubert MM. Oral manifestations of viral infections in immunocompromised patients. Curr Opin Dent. 1991;1:384-397.
41. McGuire DB, Altomonte V, Peterson DE, et al. Patterns of mucositis and pain in patients receiving preparative chemotherapy and bone marrow transplantation. Oncol Nurs Forum. 1993;20(10):1493-1520.
42. Bellm L, Cunningham G, Durnell L, et al. Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis. Cancer Invest. 2002;20:793-800.